Formex LLC - Greater San Diego Area since Mar 2013
President & CEO
Akela Pharma, Inc. - Austin, Texas Area Mar 2012 - Mar 2013
President & CEO
PharmaForm - Austin, Texas Area Mar 2012 - Mar 2013
President & CEO
Akela Pharma, Inc. Sep 2009 - Jul 2012
Chief Financial Officer
PharmaForm Sep 2009 - Jul 2012
Chief Financial Officer
Education:
University of Illinois at Urbana-Champaign - College of Business 1987 - 1991
BS, Finance
Skills:
Mergers Biotechnology Financial Reporting Financial Analysis Intellectual Property Biotech Operations IFRS Public Accounting US GAAP Operations Management SAP Pharmaceutical Industry Technology Transfer FDA Pharmaceutics Sop Mergers & Acquisitions CRO Due Diligence Forecasting Restructuring Clinical Development Lifesciences Financial Modeling Accountants Start-ups Drug Development GMP Validation
Interests:
finance, economics, biotech, startups etc.
Languages:
German
Chief Executive Officer And Chief Financial Officer And Chief Operations Officer
Intratab Labs, Inc.
Chief Operating Officer
Bridgewest Group Mar 2014 - Sep 2014
Executive Vice President of Finance
Intratab Labs, Inc. Mar 2014 - Sep 2014
Chief Executive Officer and Chief Financial Officer and Chief Operations Officer
Formex Mar 2012 - Mar 2014
Chief Executive Officer
Formex Jun 2009 - Mar 2014
Chief Operating Officer
Education:
Gies College of Business - University of Illinois Urbana - Champaign 1987 - 1991
Bachelors, Bachelor of Science, Finance
Skills:
Biotechnology Pharmaceutical Industry Start Ups Drug Development Technology Transfer Fda Clinical Development Commercialization Mergers and Acquisitions Corporate Development Finance Pharmaceutics Management Medical Devices Gmp Regulatory Affairs Financial Analysis Financial Reporting Cro Strategy Cross Functional Team Leadership Biopharmaceuticals Sop R&D Mergers Lifesciences Leadership Operations Management Sap Restructuring Validation Oncology Regulatory Submissions Venture Capital Financial Modeling Contract Manufacturing Quality Assurance Clinical Trials Drug Discovery New Business Development Intellectual Property Biotech Operations Ifrs Public Accounting Us Gaap Due Diligence Forecasting Accountants Change Control Strategic Planning Auditing